Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF) - Trial NCT06140875
Access comprehensive clinical trial information for NCT06140875 through Pure Global AI's free database. This phase not specified trial is sponsored by Charite University, Berlin, Germany and is currently Recruiting. The study focuses on Glioblastoma. Target enrollment is 26 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Charite University, Berlin, Germany
Timeline & Enrollment
N/A
Nov 15, 2023
May 14, 2029
Primary Outcome
PFS at 6 months
Summary
Combined chemoradiation and radiofrequency electromagnetic field treatment for patients with
 glioblastoma
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06140875
Device Trial